The Discounted Cash Flow (DCF) valuation of EyePoint Pharmaceuticals Inc (EYPT) is (74.87) USD. With the latest stock price at 6.37 USD, the upside of EyePoint Pharmaceuticals Inc based on DCF is -1275.4%.
Based on the latest price of 6.37 USD and our DCF valuation, EyePoint Pharmaceuticals Inc (EYPT) is a sell. selling EYPT stocks now will result in a potential gain of 1275.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 7.7% | 6.2% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (725.85) - (40.02) | (74.87) |
| Upside | -11494.8% - -728.3% | -1275.4% |